Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA91343
Max Phase: Preclinical
Molecular Formula: C22H23ClN2O3
Molecular Weight: 398.89
Molecule Type: Small molecule
Associated Items:
ID: ALA91343
Max Phase: Preclinical
Molecular Formula: C22H23ClN2O3
Molecular Weight: 398.89
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(C(=O)N/C(C(=O)N2CCCCC2)=C(/Cl)c2ccccc2)cc1
Standard InChI: InChI=1S/C22H23ClN2O3/c1-28-18-12-10-17(11-13-18)21(26)24-20(19(23)16-8-4-2-5-9-16)22(27)25-14-6-3-7-15-25/h2,4-5,8-13H,3,6-7,14-15H2,1H3,(H,24,26)/b20-19+
Standard InChI Key: RLJHHJUZMDZDJC-FMQUCBEESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 398.89 | Molecular Weight (Monoisotopic): 398.1397 | AlogP: 4.05 | #Rotatable Bonds: 5 |
Polar Surface Area: 58.64 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.19 | CX Basic pKa: | CX LogP: 3.14 | CX LogD: 3.14 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.77 | Np Likeness Score: -0.89 |
1. Perni RB, Conway SC, Ladner SK, Zaifert K, Otto MJ, King RW.. (2000) Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication., 10 (23): [PMID:11128652] [10.1016/s0960-894x(00)00544-8] |
Source(1):